Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
about
Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimizationPopulation Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in ThailandPharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infantsEvidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical AssessmentComparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteersPopulation pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam.Efficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in endemic countries: meta-analysis of randomised controlled studies.Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions.Alternative Sampling Strategies for Cytochrome P450 Phenotyping.Determination of the antimalarial drug piperaquine in small volume pediatric plasma samples by LC-MS/MS.Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda.Why dried blood spots are an ideal tool for CYP1A2 phenotyping.Strong correlation of lumefantrine concentrations in capillary and venous plasma from malaria patients
P2860
Q26830528-9A1782C0-7513-4BE3-B9B5-29047451F0CEQ31153944-668F80D5-2D9E-4C40-B251-2973B8B2EB2CQ34116219-02A8453E-E4A8-4ED6-8D56-E5823673AC3EQ35055212-DA893297-D38C-42A1-BD62-A81123031087Q35859839-E32256DD-8E49-4AD1-B5B1-48FF51451A16Q37026673-FE9DFDCE-81E6-4648-9A73-496F5EF6B56FQ37077284-3D93694C-BFB3-4269-BA59-1B0F634DC2E3Q37722332-B0D7FA10-4532-4C0C-B5FA-6BD780897426Q38065917-E3EEEAAF-ABCF-4A29-B8C0-7351046768ECQ38128343-00304D1A-741E-4C27-9B25-99D9F569FD3CQ38560254-2322C81E-2E49-4FE9-8511-497E401C3CADQ41947692-EE899836-49C9-4088-A189-8226F7C28794Q42414575-B088F294-E1EF-46C4-950A-0FFABFE97E2BQ49060953-44AFAC6E-DCB0-4198-8903-66AC43939CA2Q56342327-C081BC71-188C-48A2-BCA8-F4AF3CB1A1C4
P2860
Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Comparison of plasma, venous a ...... omplicated falciparum malaria.
@ast
Comparison of plasma, venous a ...... omplicated falciparum malaria.
@en
type
label
Comparison of plasma, venous a ...... omplicated falciparum malaria.
@ast
Comparison of plasma, venous a ...... omplicated falciparum malaria.
@en
prefLabel
Comparison of plasma, venous a ...... omplicated falciparum malaria.
@ast
Comparison of plasma, venous a ...... omplicated falciparum malaria.
@en
P2093
P2860
P50
P1476
Comparison of plasma, venous a ...... omplicated falciparum malaria.
@en
P2093
Anna Annerberg
Elizabeth A Ashley
Lucy Phaiphun
Niklas Lindegardh
P2860
P2888
P304
P356
10.1007/S00228-010-0804-7
P50
P577
2010-03-19T00:00:00Z
P5875
P6179
1000512747